Latest News[News Brief] CanSinoBIO Receives Argentine Approval for Meningococcal Vaccine[News Brief] Anixa Biosciences Secures South Korean Patent for Breast Cancer Vaccine[News Brief] Santé Accel Singapore Launches Healthcare Venture-Building Platform[News Brief] NeuroSense Reports Phase 2 Biomarker Findings for PrimeCFeatured Press ReleasesKL Wellness City: Powering Malaysia’s Healthcare TourismHealth365 Makes The News: CEO George Foo Quoted In The Business Times On Cross-Border Health Screening Surge[Press Release] – Johnson & Johnson Milestone 100,000 Eyes Implanted With TECNIS ODYSSEY IOL In The U.S. Singapore Press Releases[News Brief] Santé Accel Singapore Launches Healthcare Venture-Building Platform[News Brief] Dymax Releases Low Viscosity Medical Adhesive[News Brief] Agilent and NATi Partner on Oligonucleotide Research in SingaporeASEAN Press Releases[News Brief] Thailand FDA Approves Ravidasvir for Hepatitis C Treatment[News Brief] Philippine Pharma & Healthcare Expo 2026 Holds Media Interaction Ahead of 2026 Edition[News Brief] IMCAS Asia 2026 to Convene Dermatology and Aesthetic Medicine ProfessionalsAsia Press Releases[News Brief] CanSinoBIO Receives Argentine Approval for Meningococcal Vaccine[News Brief] Anixa Biosciences Secures South Korean Patent for Breast Cancer Vaccine[News Brief] NeuroSense Reports Phase 2 Biomarker Findings for PrimeCGlobal Press Releases[News Brief] Abbisko Expands R&D Collaboration with Eli Lilly[News Brief] Haisco Licenses Drug Candidates to Nuvectis[News Brief] CeleCor Completes FDA Application for Heart Attack Drug
Health365 Makes The News: CEO George Foo Quoted In The Business Times On Cross-Border Health Screening Surge
[Press Release] – Johnson & Johnson Milestone 100,000 Eyes Implanted With TECNIS ODYSSEY IOL In The U.S.
